<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04690556</url>
  </required_header>
  <id_info>
    <org_study_id>LRP/LUBT010/2016/008</org_study_id>
    <secondary_id>2017-004409-42</secondary_id>
    <nct_id>NCT04690556</nct_id>
  </id_info>
  <brief_title>Study to Compare Efficacy and Safety of LUBT010 and Lucentis® in Patients With Neovascular AMD</brief_title>
  <official_title>A Global, Phase III, Double Blind, Randomized Controlled Study to Compare the Efficacy, Safety &amp; Immunogenicity of LUBT010 With Lucentis® in Patients With Neovascular Age Related Macular Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lupin Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lupin Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare the efficacy, safety and immunogenicity of LUBT010 with&#xD;
      Lucentis® given as once monthly intravitreal injection in patients with neovascular&#xD;
      age-related macular degeneration (AMD).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a global, phase III, double blind, randomized controlled study to compare the&#xD;
      efficacy, safety &amp; immunogenicity of LUBT010 with Lucentis® in patients with neovascular&#xD;
      age-related macular degeneration.&#xD;
&#xD;
      Eligible patients will be randomly assigned in 1:1 ratio to receive once monthly intravitreal&#xD;
      injection of LUBT010 or Lucentis® for 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2020</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change in BCVA from baseline in the study eye at the end of 12, months assessed with the ETDRS chart</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean change in BCVA from baseline in the study eye accessed with the ETDRS chart</measure>
    <time_frame>3 months, 6 months and 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with anti-drug antibodies</measure>
    <time_frame>1, 3, 6, 9, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events (AEs)</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Number of patients with treatment-emergent adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ophthalmic examination</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Number of patients with clinically significant ophthalmic examination findings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical &amp; systemic examination</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Number of patients with clinically significant physical &amp; systemic examination findings.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital Signs</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Number of patients with clinically significant vital signs findings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECGs</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Number of patients with clinically significant ECG findings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Laboratory Tests</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Number of patients with clinically significant laboratory test findings</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Neovascular Age-related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Lucentis (ranibizumab)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravitreal injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LUBT010 (proposed ranibizumab biosimilar)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravitreal injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lucentis (ranibizumab)</intervention_name>
    <description>Lucentis® 0.5 mg via intravitreal injection once monthly</description>
    <arm_group_label>Lucentis (ranibizumab)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LUBT010 (proposed ranibizumab biosimilar)</intervention_name>
    <description>LUBT010 (proposed ranibizumab biosimilar) 0.5 mg via intravitreal injection once monthly</description>
    <arm_group_label>LUBT010 (proposed ranibizumab biosimilar)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Ambulatory male or female participants with age ≥ 50 years at the time of screening&#xD;
&#xD;
          2. Capable of understanding and giving written informed consent&#xD;
&#xD;
          3. Primary or recurrent (anti-VEGF naïve) active CNV lesions involving the foveal center&#xD;
             secondary to AMD&#xD;
&#xD;
          4. BCVA between 20/40 and 20/200 (Snellen equivalent) in the study eye, using ETDRS&#xD;
             testing&#xD;
&#xD;
          5. Willingness and ability to undertake all scheduled visits and assessments&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known hypersensitivity to ranibizumab or any of the components of study medication&#xD;
&#xD;
          2. Known history of allergy to fluorescein dye&#xD;
&#xD;
          3. Scar, fibrosis, or atrophy involving the center of the fovea in the study eye&#xD;
&#xD;
          4. Subretinal hemorrhage in the study eye that involves the center of the fovea&#xD;
&#xD;
          5. Uncontrolled glaucoma&#xD;
&#xD;
          6. Use of prohibited treatments&#xD;
&#xD;
        Other In-/Exclusion criteria may apply&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dhananjay Bakhle, M.B.B.S, M.D</last_name>
    <phone>91-20-66749000</phone>
    <phone_ext>49054</phone_ext>
    <email>dhananjaybakhle@lupin.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Eye Care Center</name>
      <address>
        <city>Guwahati</city>
        <state>Assam</state>
        <zip>781003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Ronel Soibam, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rising Retina Clinic</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380015</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Rohan Chauhan, M.B.B.S D.O</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Government Eye Hospital M &amp; J Institute of Ophthalmology</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380016</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Jignesh Gosai, MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kanoria Hospital and Research Center</name>
      <address>
        <city>Gandhinagar</city>
        <state>Gujarat</state>
        <zip>382428</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Ashish Saxena, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shivam Retina Clinic and Eye Hospital</name>
      <address>
        <city>Sūrat</city>
        <state>Gujarat</state>
        <zip>395001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Shobhana Mange, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kiran Hospital Multi Super Speciality Hospital &amp; Research Centre</name>
      <address>
        <city>Sūrat</city>
        <state>Gujarat</state>
        <zip>395004</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Kamlesh Patel, MBBS;MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kashyap Memorial Eye Hospital Pvt. Ltd.</name>
      <address>
        <city>Ranchi</city>
        <state>Jharkhand</state>
        <zip>834001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Bhibhuti Kashyap, MBBS; MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nethra Eye Hospital</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560094</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Natesh Sribhargava, MBBS;DNB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mysore Medical College and Research Institute</name>
      <address>
        <city>Mysore</city>
        <state>Karnataka</state>
        <zip>570001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr Satish K, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>JSS Hospital</name>
      <address>
        <city>Mysore</city>
        <state>Karnataka</state>
        <zip>570004</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Premnath Raman, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kamalnayan Bajaj Hospital</name>
      <address>
        <city>Aurangabad</city>
        <state>Maharashtra</state>
        <zip>431010</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Aniruddha Nalgirkar, MBBS;MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aditya Jyot Eye Hospital Pvt. Ltd.</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400031</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Jaydeep Walinjkar, MBBS; DNB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shroff Eye Hospital &amp; Vision Research Centre</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400050</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Rahul A Shroff, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Anideep Eye Hospital</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400056</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Nita U Shanbhag, MS;FCPS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Topiwala National Medical College &amp; B. Y. L. Nair Charitable Hospital</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400056</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Saroj Sahdev, MBBS;MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dhadiwal Hospital in Coalition with Shreeji Healthcare</name>
      <address>
        <city>Nashik</city>
        <state>Maharashtra</state>
        <zip>422002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Anup Shah, MBBS;MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vijay Vallabh Hospital and Medical Research Center</name>
      <address>
        <city>Palghar</city>
        <state>Maharashtra</state>
        <zip>401303</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Vinit Shah, MBBS;MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Insight Institute of Ophthalmology</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411039</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Anjali Sapar, MBBS;MS;DNB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Eye Centre Post Graduate Institute of Medical Education &amp; Research</name>
      <address>
        <city>Chandigarh</city>
        <state>Punjab</state>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Ramandeep Singh, MBBS;MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. J L Rohatgi Memorial Eye Hospital</name>
      <address>
        <city>Kanpur</city>
        <state>Uttar Pradesh</state>
        <zip>208005</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Sukant Pandey, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>King George's Medical University</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <zip>226003</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Sandeep Saxena, MBBS;MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>R.K.Netralaya Eye Hospital (P) Ltd.</name>
      <address>
        <city>Varanasi</city>
        <state>Uttar Pradesh</state>
        <zip>221010</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Atul K Sahu, MBBS;MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Institute of Ophthalmology</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700073</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Asim K Ghosh, MS (Ophthal)</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Shroff's Charity Eye Hospital</name>
      <address>
        <city>New Delhi</city>
        <zip>110002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Manisha Agarwal, MBBS;MS;DNB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sir Ganga Ram Hosptial</name>
      <address>
        <city>New Delhi</city>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Tinku B Razdan, MBBS;MS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aakash Healthcare Super Specialty Hospital</name>
      <address>
        <city>New Delhi</city>
        <zip>110075</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Vidya Nair, MD (Ophthal)</last_name>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2020</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neovascular age-related macular degeneration, Ranibizumab</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Wet Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ranibizumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to make IPD available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

